SDMHF
Sartorius Stedim Biotech S.A.
Set alert
248.00 USD -6.56 -2.58%
249.50 Day range 249.50
178.30 52-week range 264.30
- YTD
- +0.81%
- 1 year
- +2.48%
- Open
- 249.50
- Prev close
- 254.56
- Mkt cap
- 24.13B
- Vol
- 155
- Avg vol
- 1.93K
- EPS
- 3.87
- P/E
- 64.08
More statistics
- Low
- 249.50
- High
- 249.50
- Earnings
- Oct 22, 2026
Next earnings
Oct 22, 2026
Expected Oct 22, 2026. Consensus EPS estimate 1.38.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 22, 2026 | Sep 30, 2026 | 1.38 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 1.44 | 1.43 | -0.01 | -0.69% |
| Apr 23, 2026 | Mar 31, 2026 | 1.40 | 1.35 | -0.05 | -3.57% |
| Feb 16, 2026 | Dec 31, 2025 | 1.48 | 1.32 | -0.16 | -10.81% |
| Oct 16, 2025 | Sep 30, 2025 | 1.15 | 0.907 | -0.24 | -21.13% |
| Jul 22, 2025 | Jun 30, 2025 | 1.22 | 0.812 | -0.41 | -33.44% |
News
- Baron International Growth Fund Q2 2026 Portfolio Activity
- Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript
- Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing
- Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa
- Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform
- Sartorius, Sartorius Stedim Biotech shares jump after results beat
- Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript
- Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript
- Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript
- 10 stocks for investors looking for ‘wonderful companies at a fair price'
Your note
Sign in to keep a note on SDMHF — it syncs with the Stock Master app.